INFU Long Call Strategy

INFU (InfuSystem Holdings, Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on AMEX.

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

INFU (InfuSystem Holdings, Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $165.7M, a trailing P/E of 20.97, a beta of 1.49 versus the broader market, a 52-week range of 5.08-11.04, average daily share volume of 127K, a public-listing history dating back to 2007, approximately 502 full-time employees. These structural characteristics shape how INFU stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.49 indicates INFU has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a long call on INFU?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current INFU snapshot

As of May 15, 2026, spot at $8.63, ATM IV 37.50%, IV rank 3.69%, expected move 10.75%. The long call on INFU below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long call structure on INFU specifically: INFU IV at 37.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a INFU long call, with a market-implied 1-standard-deviation move of approximately 10.75% (roughly $0.93 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated INFU expiries trade a higher absolute premium for lower per-day decay. Position sizing on INFU should anchor to the underlying notional of $8.63 per share and to the trader's directional view on INFU stock.

INFU long call setup

The INFU long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With INFU near $8.63, the first option leg uses a $8.63 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed INFU chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 INFU shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$8.63N/A

INFU long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

INFU long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on INFU. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on INFU

Long calls on INFU express a bullish thesis with defined risk; traders use them ahead of INFU catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

INFU thesis for this long call

The market-implied 1-standard-deviation range for INFU extends from approximately $7.70 on the downside to $9.56 on the upside. A INFU long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current INFU IV rank near 3.69% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on INFU at 37.50%. As a Healthcare name, INFU options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to INFU-specific events.

INFU long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. INFU positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move INFU alongside the broader basket even when INFU-specific fundamentals are unchanged. Long-premium structures like a long call on INFU are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current INFU chain quotes before placing a trade.

Frequently asked questions

What is a long call on INFU?
A long call on INFU is the long call strategy applied to INFU (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With INFU stock trading near $8.63, the strikes shown on this page are snapped to the nearest listed INFU chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are INFU long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the INFU long call priced from the end-of-day chain at a 30-day expiry (ATM IV 37.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a INFU long call?
The breakeven for the INFU long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current INFU market-implied 1-standard-deviation expected move is approximately 10.75%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on INFU?
Long calls on INFU express a bullish thesis with defined risk; traders use them ahead of INFU catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current INFU implied volatility affect this long call?
INFU ATM IV is at 37.50% with IV rank near 3.69%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related INFU analysis